The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Voluntary Field Corrective Action Issued for GE Healthcare's Engström Ventilator and Aespire View, Aisys, and Avance Anesthesia Machines

Wednesday, October 16, 2013

Voluntary Field Corrective Action Issued for GE Healthcare's Engström Ventilator and Aespire View, Aisys, and Avance Anesthesia Machines

10:36 EDT Wednesday, October 16, 2013

MADISON, Wis. (Business Wire) -- GE Healthcare has initiated a voluntary field corrective action for the Engström ventilator and Aespire View, Aisys, and Avance anesthesia machines due to a potential safety issue. The affected units were manufactured between the dates of April 23, 2013 and July 22, 2013.

Clinicians may continue to use their Engström ventilator and Aespire View, Aisys, and Avance anesthesia machines, but should be aware of a potential safety issue involving unresponsive buttons on the display of the Engström ventilator and Aespire View, Aisys, and Avance anesthesia machines. Due to a manufacturing issue, the buttons on the left, right, and bottom keypads may not always detect a user's button presses. This may result in the inability to access certain menu functions which could possibly lead to delay in treatment.

GE Healthcare has begun notifying customers with affected units through an Urgent Medical Device Correction letter, which alerts users of the concern and provides instructions to mitigate the issue. The instructions explain that to mitigate this issue: (1) The user may notice that a button press may not actuate the desired function. Usually by pressing the key again, the device will respond as expected. (2) If a button has no response, the menu function may be accessible through the use of the control wheel. The instructions direct that if none of the above steps can be performed, discontinue use and contact a GE Healthcare Service Representative.

GE Healthcare is following up with all customers and will correct all affected systems at no cost to customers. To date, no patient injuries have been reported with regards to this issue.

For additional information regarding this field action, please contact GE Healthcare's Customer Service line (24 hours a day, 7 days a week) at 1-800-345-2700.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA:

  • Online at http://www.fda.gov/Safety/MedWatch/HowToReport/default.htm (form available to fax or email), or
  • Call FDA 1-800-FDA-1088.

GE Healthcare
Annette Busateri, +1-262-442-0966
annette.busateri@ge.com

Products
  • The Globe and Mail Newspaper

    Newspaper delivered to your doorstep. subscribe

  • Globe Unlimited

    Digital all access pass across devices. subscribe

  • The Globe and Mail App

    The New Globe and Mail App for iPhone®, iPad® and Apple Watch download

  • Globe2Go

    The digital replica of our newspaper. subscribe

  • Globe eBooks

    A collection of articles by the Globe. subscribe

See all Globe Products

Advertise with us

GlobeLink.ca

Your number one partner for reaching Canada's Influential Achievers. learn more

The Globe at your Workplace
Our Company
Secure Service
Customer Service
Advertising Privacy
Globe Recognition
Mobile Apps
NEWS APP
Other Sections